BACKGROUND/AIMS: Optic pathway gliomas (OPGs) may cause progressive visual loss despite chemotherapy. Newer, less toxic treatments might be given earlier, depending on visual prognosis. We aimed to investigate the prognostic value of visual evoked potentials (VEP) and optical coherence tomography (OCT). METHODS: A retrospective study of OPG patients (treated 2003–2017) was conducted. Primary outcome was PEDIG category visual acuity in better and worse eyes (good = 0.7 logMAR). Binary logistic regression analysis was used to identify predictors of these outcomes. RESULTS: 60 patients (32 Neurofibromatosis type 1 [NF1] and 28 sporadic) had median presentation age 49 months (range 17–183) (NF1) and 27 months (range 4–92) (sporadic). Median fo...
We evaluated the visual outcome of a cohort of children with neurofibromatosis type 1 (NF1) and opti...
Optic pathway gliomas (OPGs) occur in 15%-20% of children with neurofibromatosis type 1 (NF1), leadi...
Optic pathway glioma (OPG) occurs in as many as one-fifth of individuals with the neurofibromatosis ...
BACKGROUND/AIMS: Optic pathway gliomas (OPGs) may cause progressive visual loss despite chemotherapy...
Optic pathway glioma (OPG) presents in childhood and can cause significant morbidity and visual loss...
Optic Pathway Glioma (OPG) is a relatively common brain tumour in childhood; however, there is scarc...
Background: The aim of the project was to identify risk factors associated with visual progression ...
Background: Optic pathway gliomas (OPGs), also known as visual pathway gliomas, are debilitating tu...
PURPOSE: To compare visual function assessment, optic disc evaluation by indirect ophthalmoscopy, a...
Abstract BACKGROUND: Little is known about the visual outcome of children affected by an optic p...
BACKGROUND: Visual outcome is one of the main issues in the treatment of optic pathway glioma in chi...
Background Optic Pathway Gliomas (OPGs) are a type of benign tumour found in paediatric cohorts t...
Background/Objectives: The optic pathway glioma affected 15-20% of children with neurofibromatosis t...
Survival rates for children with brain cancer have dramatically increased in the recent decades, but...
We evaluated the visual outcome of a cohort of children with neurofibromatosis type 1 (NF1) and opti...
We evaluated the visual outcome of a cohort of children with neurofibromatosis type 1 (NF1) and opti...
Optic pathway gliomas (OPGs) occur in 15%-20% of children with neurofibromatosis type 1 (NF1), leadi...
Optic pathway glioma (OPG) occurs in as many as one-fifth of individuals with the neurofibromatosis ...
BACKGROUND/AIMS: Optic pathway gliomas (OPGs) may cause progressive visual loss despite chemotherapy...
Optic pathway glioma (OPG) presents in childhood and can cause significant morbidity and visual loss...
Optic Pathway Glioma (OPG) is a relatively common brain tumour in childhood; however, there is scarc...
Background: The aim of the project was to identify risk factors associated with visual progression ...
Background: Optic pathway gliomas (OPGs), also known as visual pathway gliomas, are debilitating tu...
PURPOSE: To compare visual function assessment, optic disc evaluation by indirect ophthalmoscopy, a...
Abstract BACKGROUND: Little is known about the visual outcome of children affected by an optic p...
BACKGROUND: Visual outcome is one of the main issues in the treatment of optic pathway glioma in chi...
Background Optic Pathway Gliomas (OPGs) are a type of benign tumour found in paediatric cohorts t...
Background/Objectives: The optic pathway glioma affected 15-20% of children with neurofibromatosis t...
Survival rates for children with brain cancer have dramatically increased in the recent decades, but...
We evaluated the visual outcome of a cohort of children with neurofibromatosis type 1 (NF1) and opti...
We evaluated the visual outcome of a cohort of children with neurofibromatosis type 1 (NF1) and opti...
Optic pathway gliomas (OPGs) occur in 15%-20% of children with neurofibromatosis type 1 (NF1), leadi...
Optic pathway glioma (OPG) occurs in as many as one-fifth of individuals with the neurofibromatosis ...